Petros Pharmaceuticals Stock Volatility

PTPI Stock  USD 0.30  0.01  3.23%   
Petros Pharmaceuticals is out of control at the moment. Petros Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.0139, which implies the firm had a 0.0139% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Petros Pharmaceuticals, which you can use to evaluate the volatility of the company. Please check Petros Pharmaceuticals' Risk Adjusted Performance of 0.0442, coefficient of variation of 2402.93, and Semi Deviation of 7.65 to confirm if the risk estimate we provide is consistent with the expected return of 0.19%. Key indicators related to Petros Pharmaceuticals' volatility include:
720 Days Market Risk
Chance Of Distress
720 Days Economic Sensitivity
Petros Pharmaceuticals Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Petros daily returns, and it is calculated using variance and standard deviation. We also use Petros's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Petros Pharmaceuticals volatility.
  
Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Petros Pharmaceuticals at lower prices. For example, an investor can purchase Petros stock that has halved in price over a short period. This will lower their average cost per share, thereby improving the overall portfolio performance when market normalizes.

Moving against Petros Stock

  0.36VERA Vera TherapeuticsPairCorr
  0.33VANI Vivani MedicalPairCorr

Petros Pharmaceuticals Market Sensitivity And Downside Risk

Petros Pharmaceuticals' beta coefficient measures the volatility of Petros stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Petros stock's returns against your selected market. In other words, Petros Pharmaceuticals's beta of -0.34 provides an investor with an approximation of how much risk Petros Pharmaceuticals stock can potentially add to one of your existing portfolios. Petros Pharmaceuticals is showing large volatility of returns over the selected time horizon. Petros Pharmaceuticals is a potential penny stock. Although Petros Pharmaceuticals may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Petros Pharmaceuticals. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Petros instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze Petros Pharmaceuticals Demand Trend
Check current 90 days Petros Pharmaceuticals correlation with market (Dow Jones Industrial)

Petros Beta

    
  -0.34  
Petros standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  13.77  
It is essential to understand the difference between upside risk (as represented by Petros Pharmaceuticals's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Petros Pharmaceuticals' daily returns or price. Since the actual investment returns on holding a position in petros stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Petros Pharmaceuticals.

Petros Pharmaceuticals Stock Volatility Analysis

Volatility refers to the frequency at which Petros Pharmaceuticals stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Petros Pharmaceuticals' price changes. Investors will then calculate the volatility of Petros Pharmaceuticals' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Petros Pharmaceuticals' volatility:

Historical Volatility

This type of stock volatility measures Petros Pharmaceuticals' fluctuations based on previous trends. It's commonly used to predict Petros Pharmaceuticals' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Petros Pharmaceuticals' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Petros Pharmaceuticals' to be redeemed at a future date.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Petros Pharmaceuticals Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.

Petros Pharmaceuticals Projected Return Density Against Market

Given the investment horizon of 90 days Petros Pharmaceuticals has a beta of -0.3424 indicating as returns on the benchmark increase, returns on holding Petros Pharmaceuticals are expected to decrease at a much lower rate. During a bear market, however, Petros Pharmaceuticals is likely to outperform the market.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Petros Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Petros Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Petros stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Petros Pharmaceuticals has an alpha of 0.5686, implying that it can generate a 0.57 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Predicted Return Density   
       Returns  
Petros Pharmaceuticals' volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how petros stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives a Petros Pharmaceuticals Price Volatility?

Several factors can influence a stock's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Petros Pharmaceuticals Stock Risk Measures

Given the investment horizon of 90 days the coefficient of variation of Petros Pharmaceuticals is 7183.77. The daily returns are distributed with a variance of 189.59 and standard deviation of 13.77. The mean deviation of Petros Pharmaceuticals is currently at 7.01. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.84
α
Alpha over Dow Jones
0.57
β
Beta against Dow Jones-0.34
σ
Overall volatility
13.77
Ir
Information ratio 0.04

Petros Pharmaceuticals Stock Return Volatility

Petros Pharmaceuticals historical daily return volatility represents how much of Petros Pharmaceuticals stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 13.7693% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.8496% volatility on return distribution over the 90 days horizon.
 Performance 
       Timeline  

About Petros Pharmaceuticals Volatility

Volatility is a rate at which the price of Petros Pharmaceuticals or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Petros Pharmaceuticals may increase or decrease. In other words, similar to Petros's beta indicator, it measures the risk of Petros Pharmaceuticals and helps estimate the fluctuations that may happen in a short period of time. So if prices of Petros Pharmaceuticals fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Last ReportedProjected for Next Year
Market Cap3.5 M3.4 M
Petros Pharmaceuticals' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Petros Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Petros Pharmaceuticals' price varies over time.

3 ways to utilize Petros Pharmaceuticals' volatility to invest better

Higher Petros Pharmaceuticals' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Petros Pharmaceuticals stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Petros Pharmaceuticals stock volatility can provide helpful information for making investment decisions in the following ways:
  • Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Petros Pharmaceuticals investment. A higher volatility means higher risk and potentially larger changes in value.
  • Identifying Opportunities: High volatility in Petros Pharmaceuticals' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
  • Diversification: Understanding how the volatility of Petros Pharmaceuticals' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Remember it's essential to remember that stock volatility is just one of many factors to consider when making investment decisions, and it should be used in conjunction with other fundamental and technical analysis tools.

Petros Pharmaceuticals Investment Opportunity

Petros Pharmaceuticals has a volatility of 13.77 and is 16.2 times more volatile than Dow Jones Industrial. 96 percent of all equities and portfolios are less risky than Petros Pharmaceuticals. You can use Petros Pharmaceuticals to protect your portfolios against small market fluctuations. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Petros Pharmaceuticals to be traded at $0.288 in 90 days.

Good diversification

The correlation between Petros Pharmaceuticals and DJI is -0.02 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Petros Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Petros Pharmaceuticals Additional Risk Indicators

The analysis of Petros Pharmaceuticals' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Petros Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some common measures of Petros Pharmaceuticals stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Petros Pharmaceuticals Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Petros Pharmaceuticals as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Petros Pharmaceuticals' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Petros Pharmaceuticals' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Petros Pharmaceuticals.

Complementary Tools for Petros Stock analysis

When running Petros Pharmaceuticals' price analysis, check to measure Petros Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Petros Pharmaceuticals is operating at the current time. Most of Petros Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Petros Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Petros Pharmaceuticals' price. Additionally, you may evaluate how the addition of Petros Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Valuation
Check real value of public entities based on technical and fundamental data